现代中药集团（香港联交所编号：01643）于2026年10月2日发布2026年9月股份变动月报表，报告期为2026年9月1日至9月30日。公告显示，截至报告期末，公司的法定注册股本维持在10,000,000,000股，每股面值港币0.01元，总计港币100,000,000元；已发行股份总数则与上月一致，保持在720,000,000股，无新增发行、购回、注销或库藏股变动。
同时，公告披露公司并未在本期内执行任何股份期权、认股权证或可换股票据，也无其他影响已发行股份或库存股份数量的法律协议或安排。公司确认目前已满足香港联交所的公众持股量要求，并将继续遵守相关监管规定。以上信息由公司执行董事张宏丽签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.